JATT Acquisition Corp. (JATT) to Combine with Zura Bio in $215M Deal

Jun 17, 2022 INTEL by Nicholas Alan Clayton

JATT (NYSE:JATT) has entered into a definitive agreement to combine with biotech firm Zura Bio at an enterprise value of $215 million. London-based Zura Bio is a clinical-stage firm developing novel medicines for immune disorders with an initial focus on alopecia. The combined company is expected to trade on the NYSE under the symbol “ZURA”
Read More

To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.

JATT Acquisition Corp. (JATT) to Combine with Zura Bio in $215M Deal

JATT Acquisition Corp. (JATT) to Combine with Zura Bio in $215M Deal

ByNicholas Alan Clayton